Prenetics Global Ltd. (PRE.US), the combined company of Prenetics Group Ltd., the Hong Kong-based biotech firm, and Artisan Acquisition Corp., a special purpose acquisitions company (SPAC), has been successfully listed on NASDAQ on 18 May 2022. AVISTA Group is honored to be engaged in providing valuation services with regards to the first Hong Kong-based unicorn’s listing application on NASDAQ via a SPAC merger. Prenetics Group Ltd. is a global leader in genomic and diagnostic testing with significant operations in Hong Kong and the U.K. Known for its COVID-19 testing services, the billion-dollar start-up reported a record-high US$92 million in revenue for the first quarter of 2022, representing a 60.2% year-on-year growth. Prenetics Group Ltd. has a robust product pipeline and has launched a range of new products in the first half of 2022, including ColoClear, a non-invasive stool DNA test for colon cancer screening, and Circle Snapshot, an at-home painless blood collection device with a user-friendly sample collection and result delivery system. Artisan Acquisition Corp. (ARTAU.US) is a SPAC which searches globally for a target with operations or prospects focusing on high-growth healthcare, consumer and technology sectors, and companies that it believes can be well-positioned for success in Greater China. The merger is expected to raise up to US$459 million proceeds for Prenetics upon the completion of de-SPAC transaction. UBS, Citi, Credit Suisse and CICC are financial advisors on the de-SPAC transaction. <img src="../../../../../uploads/Prenetics_EN_0be7bbf215.PNG" alt="" width="533" height="400" />

Congratulations to Prenetics Global Ltd. (PRE.US)–First Hong Kong Unicorn Going Public via SPAC Merger–on its Successful Listing 

Yunkang Group Ltd. (2325.HK) has been successfully listed on the Mainboard of HKSE on 18 May 2022. AVISTA Group is honored to be engaged in providing valuation services with regards to this listing application. Yunkang is a medical operation service provider in China established in 2008, primarily engaged in offering a full suite of diagnostic testing services for medical institutions. The group was among the top five major medical operation service providers in China in 2020, with a market share of 3.7% in terms of revenue, according to Frost &amp; Sullivan. Yunkang also ranked the second largest provider in China’s diagnostic testing services for medical institution alliances market in 2020, accounted for a 12.5% market share. The outbreak of the COVID-19 pandemic, and the subsequent growth in market needs for diagnostic services and supplies, the COVID-19 test kits in particular, have contributed to a surge in demand for Yunkang’s diagnostic outsourcing services, presenting a higher gross-profit margin accompanied by economies of scale.  Located in a diagnostic outsourcing service market with sizable growth potential, and equipped with its own reliable diagnostic capabilities and a nationwide customer base, currently Yunkang operates three lines of business, namely diagnostic testing services for medical institution alliances, diagnostic outsourcing services and diagnostic testing services via outpatient clinic for non-medical institution customers. The group targets to continue expanding its on-site diagnostic center network to capture a larger market share. <img src="../../../../../uploads/2325_HK_EN_fe4921a7c5.PNG" alt="" width="533" height="400" />

Congratulations to Yunkang Group Ltd. (2325.HK) on its Successful Listing

Our Managing Director, Mr. Vincent Pang, was pleased to be invited by The Hong Kong Chartered Governance Institute (HKCGI) to present a webinar titled “Valuation in Practice: from Fundraising to IPOs and Beyond” on 11 May 2022. The webinar is dedicated to sharing important valuation specific experience and related up-to-date knowledge applicable in the course of corporate development, from start-up to IPO stages and subsequent M&amp;A activities, to a room of over 200 corporate leaders and decision makers. From the perspective of an industry veteran, Vincent delved into various approaches of valuation practice that support and enable informed decision-making, robust strategic planning and sustainable growth of a company. The prevailing reporting frameworks and standards, as well as regulators of concern were also introduced to provide a comprehensive view of how to make inroads into effective corporate governance augmented by a credible and professional valuation services provider. <img src="../../../../../uploads/1_5ecec2af98.png" alt="" width="533" height="300" /> <img src="../../../../../uploads/2a_e6ea7857b1.png" alt="" width="533" height="300" />

banner1

As Speaker of the HKCGI Webinar – “Valuation in Practice: from Fundraising to IPOs and Beyond”

<div class="cxmmr5t8 oygrvhab hcukyx3x c1et5uql o9v6fnle ii04i59q">
<div dir="auto"><img style="display: block; margin-left: auto; margin-right: auto;" src="../../../../../uploads/2_e193de471f.png" alt="" width="425" height="300" /> We are proud to announce that AVISTA Hong Kong is moving to a new location with  upgraded smart office, extra excollaborative spaces, sustainable features and enhanced functionality, in response to its fast-growing business and team expansion. The relocation of our headquarters marks an important step in our company’s continuing growth trajectory and a significant milestone to celebrate.</div>
<div dir="auto"> </div>
</div>
<div class="cxmmr5t8 oygrvhab hcukyx3x c1et5uql o9v6fnle ii04i59q">
<div dir="auto">Hong Kong Office (new address with effect from April 29, 2022): Suites 2401-06, 24/F, Everbright Centre, 108 Gloucester Road, Wan Chai, Hong Kong</div>
<div dir="auto"> </div>
</div>
<div class="cxmmr5t8 oygrvhab hcukyx3x c1et5uql o9v6fnle ii04i59q">
<div dir="auto">We very much look forward to serving you at our new location. <img src="../../../../../uploads/IMG_3748_2_1635bfef3f.jpeg" alt="" width="400" height="300" /> <img src="../../../../../uploads/IMG_3593_2_22e59ba3b8.jpeg" alt="" width="400" height="300" /> <img src="../../../../../uploads/IMG_3749_2_359b0d03f3.jpeg" alt="" width="400" height="300" /> <img src="../../../../../uploads/IMG_3597_3_6997a124a7.png" alt="" width="400" height="300" /> <img src="../../../../../uploads/IMG_3607_3_6dcd23205d.png" alt="" width="400" height="300" /> <img src="../../../../../uploads/IMG_3647_2_c1eeece6c2.jpeg" alt="" width="400" height="300" /> <img src="../../../../../uploads/IMG_3578_4_352256068c.png" alt="" width="400" height="300" /> <img src="../../../../../uploads/IMG_3639_3_854b14b774.png" alt="" width="400" height="300" /> </div>
</div>

IMG_3593_2.jpeg

Important Notice: AVISTA Hong Kong Upgrades to a New Office Space 

Our Managing Director, Mr. Vincent Pang, was pleased to be invited by The Chinese University of Hong Kong (CUHK) Business School to give a guest lecture, titled “Integrating Corporate Valuation, Risk Management &amp; ESG into Corporate Venturing Strategy”, in an undergraduate business course to over 100 students online on 24 March 2022. Leveraged his deep expertise and insights in areas of corporate valuation, risk management and ESG advisory, Vincent explored the essence and mutually reinforcing relationship of these service areas, and, by approaching the practical aspect, elaborated on how to integrate them when formulating corporate strategy in achieving growth ambitions. Vincent also touched on the indispensable role played by digital innovation in today’s business advisory service, which has been deemed traditional; and last but not least, shared his inspiring journey on leading a fast-growing company and becoming a trustful corporate partner. <img src="../../../../../uploads/cuhk_guest_lecture_1_885357da48.png" alt="" width="510" height="250" /> <img src="../../../../../uploads/cuhk_guest_lecture_2_b2519d32ba.png" alt="" width="510" height="319" /> <img src="../../../../../uploads/cuhk_guest_lecture_poster_6991fb8a50.png" alt="" width="510" height="722" />

pinwheel-1716620_1920

As Guest Speaker at CUHK Business School Undergraduate Lecture

Aquila Acquisition Corporation has been successfully listed on the Mainboard of HKSE on 18 March 2022. AVISTA Group is honored to be engaged in providing valuation services with regards to the first-ever special purpose acquisition company (SPAC) listing application on the Hong Kong Stock Exchange (HKSE). Co-founded by CMB International and AAC Management Holding Ltd., Aquila is the first SPAC in Hong Kong to make an IPO under the new SPAC listing mechanism, which came into effect on 1 January this year. Aquila has been formed for the purpose of effecting a business combination (“De-SPAC Transaction”) with one or more businesses (“De-SPAC Targets”). In identifying its De-SPAC Targets, Aquila intends to concentrate efforts on technology-enabled companies in new economy sectors, such as green energy, life sciences and advanced technology and manufacturing in Asia, with a focus on China, yet they may pursue a De-SPAC Target in any sector. <img src="../../../../../uploads/Aquila_EN_congrat_ad_900948f019.PNG" alt="" width="667" height="500" /> <img src="../../../../../uploads/Aquila_EN_AVISTA_049e37d0d0.png" alt="" width="667" height="443" />

Congratulations to Hong Kong’s First-ever SPAC IPO – Aquila Acquisition Corporation (7836.HK) on its Successful Listing

To accommodate our continuously growing business in Shanghai market and facilitate a better work environment for our colleagues, it is our pleasure to announce that AVISTA Group’s Shanghai Office will be relocated to a more spacious and modern premise at below address with effect from March 15, 2022. Shanghai Office (new address): Unit C, 23/F, Phase Ⅱ, Sino-Ocean Tower, 618 East Yan An Road, Huangpu District, Shanghai, PRC We very much look forward to continuing serving you at our new location. <img src="../../../../../uploads/Relocation_Notice_EN_3_cropped_31b86d93b8.png" alt="" width="533" height="358" /> <img src="../../../../../uploads/SH_Office_entrance_301f5a72bb.jpg" alt="" width="533" height="355" />
<img src="../../../../../uploads/SH_Office_meeting_room_e5789901ba.jpg" alt="" width="533" height="400" />
<img src="../../../../../uploads/SH_office_space_2_7ad4fa51ea.jpg" alt="" width="533" height="358" />
<img src="../../../../../uploads/logo_wall_resized_0b9f960216.jpg" alt="" width="533" height="355" />

News